GVR Report cover DNA Microarray Market Size, Share & Trends Report

DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application, By End-user, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453987
  • Number of Pages: 0
  • Format: Electronic (PDF)

DNA microarray is a biotechnology tool used to detect changes in gene expression levels by analyzing a small sample of DNA to study the expression of thousands of genes simultaneously. This technique uses a DNA sample to create a "probe" that is placed on a glass slide containing different gene sequences. The probe binds to the gene sequences it is looking for, allowing researchers to measure the amount of mRNA produced from that gene. This data can be used to understand how a gene is expressed in different conditions or contexts. DNA microarray technology has revolutionized genomics by allowing researchers to study gene expression patterns in a more efficient and accurate manner, but it has limitations such as the detection of changes over time, the accuracy of data, and cost.

The DNA microarray market is growing due to advancements in technology and increasing investment in R&D by key players. Factors such as the increasing prevalence of genetic diseases, rising applications in personalized medicine, and growing use in gene expression research are also driving market growth. For instance, in a study by researchers from the National Defense Medical Center in Taiwan, DNA microarray was used in gene expression profiles to examine the immunofunctionomes of ovarian clear cell carcinoma at different stages. Furthermore, strategic partnerships and investments in R&D by companies also play an important part in development of this market. For instance, In Fabruary 2019 Mobidiag Ltd. had completed a EUR10 million-equity investment from Autobio Diagnostics that helped contribute to market growth and demonstrate the potential of DNA microarray technology in fields such as medical research and diagnostics.

The market is segmented based on product, application, end-use, and region. The type segment includes complementary DNA microarrays and oligonucleotide DNA microarrays. The application segment is segmented into gene expression analysis and genotyping. The end-use segment is further segmented into pharmaceutical and biotechnology companies, diagnostic centers, hospitals and clinics, and academic and research institutes.

Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In North America, DNA microarray technology is being used in a variety of research settings, from academic laboratories to biopharmaceutical companies. In Europe, DNA microarray technology is being used to investigate the genetic basis of diseases and to identify genetic markers associated with different phenotypes. In Asia Pacific, DNA microarray technology is being used to develop diagnostic tests for diseases and to identify drug targets. In Latin America, DNA microarray technology is being used to identify genetic variants associated with diseases and to develop new treatments. Finally, in the Middle East & Africa, DNA microarray technology is being used to identify genetic variants associated with diseases and to assess gene expression levels.

                                               DNA Microarray Market Segmentation




Complementary DNA Microarrays

Oligonucleotide DNA Microarrays

Others- BAC clone chips


Gene Expression Analysis



End user

Pharmaceutical and Biotechnology Companies,

Diagnostic Centers

Hospitals and Clinics

Academic and Research Institute



North America (U.S., Canada),

Europe (UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway)

Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)

Latin America (Brazil, Mexico, Argentina),

Middle East & Africa (Saudi Africa, South Arabia, UAE, Kuwait)


The key players of the DNA Microarray market include F. Hoffmann-La Roche Ltd., Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Merck KGaA, bioMerieux SA, PerkinElmer, Inc., GE HEalthcare, and Affymetrix, Inc. These key players have been developing technologies for DNA microarray and providing products and services to the customers. They have been introducing various innovations in the market and expanding their product portfolios in order to stay competitive in the market. They also focus on strategic collaborations with other players in the market, thus creating a strong presence in the market.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon